Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
6.62
+0.11 (1.69%)
At close: Mar 2, 2026, 4:00 PM EST
6.55
-0.07 (-1.06%)
Pre-market: Mar 3, 2026, 7:00 AM EST
AVR Market Cap
AVR has a market cap or net worth of $621.43 million as of March 3, 2026. Its market cap has increased by 112.91% in one year.
Market Cap
621.43M
Enterprise Value
610.89M
1-Year Change
112.91%
Ranking
Category
Stock Price
$6.62
Market Cap Chart
Since the IPO on October 23, 2017, AVR's market cap has increased from $49.67M to $621.43M, an increase of 1,151.08%. That is a compound annual growth rate of 35.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 604.27M | 184.62% |
| Dec 31, 2025 | 212.31M | 15.42% |
| Dec 31, 2024 | 183.94M | -20.93% |
| Dec 29, 2023 | 232.62M | 10.90% |
| Dec 30, 2022 | 209.76M | 100.65% |
| Dec 31, 2021 | 104.54M | 525.78% |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtriCure | 1.54B |
| Kestra Medical Technologies | 1.33B |
| Pulse Biosciences | 1.28B |
| Azenta | 1.19B |
| BioLife Solutions | 1.09B |
| Anbio Biotechnology | 1.01B |
| STAAR Surgical Company | 947.58M |
| Embecta | 591.61M |